Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-25 Purchase |
2022-05-27 4:09 pm |
Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER |
2,551 | $3.92 | $10,000 | 332,685 (Direct) |
View |
| 2022-05-17 Purchase |
2022-05-18 7:28 pm |
Immuneering Corp | IMRX | Bookman Michael GENERAL COUNSEL AND SECRETARY |
1,000 | $4.88 | $4,880 | 2,402 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-17 5:15 pm |
Immuneering Corp | IMRX | KEATING LAURIE Director |
7,000 | $5 | $35,000 | 14,000 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-12 5:37 pm |
Immuneering Corp | IMRX | Amin Biren CFO, TREASURER |
1,000 | $4.42 | $4,420 | 7,898 (Direct) |
View |
| 2022-03-23 Purchase |
2022-03-24 4:39 pm |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
3,000 | $8.02 | $24,060 | 3,152,279 (Indirect Direct) |
View |
| 2022-03-23 Purchase |
2022-03-23 6:38 pm |
Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER |
1,050 | $7.91 | $8,306 | 330,134 (Direct) |
View |
| 2022-03-22 Purchase |
2022-03-22 6:49 pm |
Immuneering Corp | IMRX | Barrett Scott CHIEF MEDICAL OFFICER |
900 | $7.485 | $6,737 | 7,563 (Direct) |
View |
| 2022-03-15 Purchase |
2022-03-16 5:30 pm |
Immuneering Corp | IMRX | Feinberg Peter Director |
6,667 | $6.75 | $45,002 | 996,064 (Indirect Direct) |
View |
| 2022-03-15 Purchase |
2022-03-15 5:53 pm |
Immuneering Corp | IMRX | BERMAN ANN E Director |
6,000 | $6.4 | $38,400 | 9,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-08 Option Award |
2024-02-09 4:12 pm |
N/A 2034-02-08 |
Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER |
130,900 | $0 | 130,900 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-09 4:07 pm |
N/A 2034-02-08 |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
260,700 | $0 | 260,700 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:31 pm |
N/A 2034-01-01 |
Immuneering Corp | IMRX | KEATING LAURIE Director |
6,879 | $0 | 6,879 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:26 pm |
N/A 2034-01-01 |
Immuneering Corp | IMRX | Feinberg Peter Director |
6,879 | $0 | 6,879 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:44 pm |
N/A 2033-06-14 |
Immuneering Corp | IMRX | KEATING LAURIE Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:39 pm |
N/A 2033-06-14 |
Immuneering Corp | IMRX | HAUSMAN DIANA Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:35 pm |
N/A 2033-06-14 |
Immuneering Corp | IMRX | Feinberg Peter Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:30 pm |
N/A 2033-06-14 |
Immuneering Corp | IMRX | CARPENTER ROBERT J Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:25 pm |
N/A 2033-06-14 |
Immuneering Corp | IMRX | BERMAN ANN E Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-14 4:15 pm |
N/A 2033-06-13 |
Immuneering Corp | IMRX | Morales Mallory VICE PRESIDENT, FINANCE |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2023-04-24 5:21 pm |
N/A N/A |
Immuneering Corp | IMRX | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Chen Bihua 10% Owner |
0 | $0 | 4,204,364 (Indirect) |
View |
| 2023-03-31 Option Award |
2023-04-03 4:54 pm |
N/A 2033-03-31 |
Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:30 pm |
N/A 2033-02-15 |
Immuneering Corp | IMRX | Morales Mallory VICE PRESIDENT, FINANCE |
72,000 | $0 | 72,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:16 pm |
N/A 2033-02-15 |
Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER |
187,000 | $0 | 187,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:16 pm |
N/A 2033-02-15 |
Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER |
105,000 | $0 | 105,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:16 pm |
N/A 2033-02-15 |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
374,000 | $0 | 726,244 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:15 pm |
N/A 2033-02-15 |
Immuneering Corp | IMRX | Barrett Scott CHIEF MEDICAL OFFICER |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:15 pm |
N/A 2033-02-15 |
Immuneering Corp | IMRX | Bookman Michael GENERAL COUNSEL AND SECRETARY |
143,000 | $0 | 143,000 (Direct) |
View |
| 2022-12-22 Exercise |
2022-12-27 08:14 am |
N/A 2029-12-15 |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
2,500 | $0 | 3,360,279 (Direct) |
View |
| 2022-12-22 Exercise |
2022-12-27 08:14 am |
N/A N/A |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
2,500 | $3.01 | 3,360,279 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 09:03 am |
N/A 2032-10-31 |
Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER |
88,600 | $0 | 88,600 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-12 4:15 pm |
N/A 2032-08-11 |
Immuneering Corp | IMRX | Morales Mallory VICE PRESIDENT, FINANCE |
10,000 | $0 | 10,000 (Direct) |
View |
Ownership |
2022-08-11 08:48 am |
N/A N/A |
Immuneering Corp | IMRX | Morales Mallory Vice President, Finance |
0 | $0 | 56,764 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 5:08 pm |
N/A 2032-06-20 |
Immuneering Corp | IMRX | BERMAN ANN E Director |
14,200 | $0 | 14,200 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 5:06 pm |
N/A 2032-06-20 |
Immuneering Corp | IMRX | Feinberg Peter Director |
14,200 | $0 | 14,200 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 5:00 pm |
N/A 2032-06-20 |
Immuneering Corp | IMRX | CARPENTER ROBERT J Director |
14,200 | $0 | 14,200 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 4:59 pm |
N/A 2032-06-20 |
Immuneering Corp | IMRX | KEATING LAURIE Director |
14,200 | $0 | 14,200 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 4:56 pm |
N/A 2032-06-20 |
Immuneering Corp | IMRX | HAUSMAN DIANA Director |
6,185 | $0 | 6,185 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-14 4:30 pm |
N/A 2029-12-15 |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
2,000 | $0 | 3,360,279 (Direct) |
View |
| 2022-04-12 Exercise |
2022-04-14 4:30 pm |
N/A N/A |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
2,000 | $3.01 | 3,360,279 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 5:19 pm |
N/A 2029-12-15 |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
2,000 | $0 | 3,357,279 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-01 5:19 pm |
N/A N/A |
Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner |
2,000 | $3.01 | 3,357,279 (Direct) |
View |